Skip to content

Impact of Neurostimulation on Patterns of Brain Electrical Activity in Patients With Tinnitus

IMPACT OF TRANSCRANIAL DIRECT CURRENT STIMULATION ON THE STANDARDS OF CEREBRAL ELECTRIC ACTIVITY IN PATIENTS WITH CHRONIC TINNITUS: CLINICAL TRIAL, DOUBLE BLIND, PLACEBO-CONTROLLED

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03036137
Enrollment
54
Registered
2017-01-30
Start date
2017-02-01
Completion date
2017-09-01
Last updated
2017-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Keywords

Tinnitus, Electroencephalogram, Transcranial Direct Current Stimulation

Brief summary

Relating the electroencephalogram findings of patients with tinnitus before and after a therapeutic modality is still scarce in the literature, especially with neuromodulatory methods, more specifically with Transcranial Direct Current Stimulation - tDCS. This study is a double blind, sham-controlled clinical trial aiming investigate the impact of tDCS on patterns of brain electrical activity in patients with chronic tinnitus. 36 volunteers with tinnitus will be allocated randomly in 2 groups: the first (n = 18) will receive anodic tDCS in the temporoparietal left area and cathode in the right dorsolateral prefrontal cortex and the second group (n = 18) correspond to the sham group. In addition, healthy individuals (n = 18) will be recruited for comparative purposes of brain electrical activity with and without tinnitus, totaling 54 participants. Patients with tinnitus will receive transcranial direct current stimulation for 20 minutes for 5 consecutive days (1 week) and will be assessed before and after intervention by electroencephalogram, Acuphenometry, Visual Analogue Scale - VAS and questionnaire Tinnitus Handicap Inventory- THI. Follow-up of volunteers will also be performed after 1 month of the end of treatment with tDCS.

Interventions

DEVICETranscranial Direct Current Stimulation

Anodal stimulation of the temporoparietal left area with an cathode over the right dorsolateral prefrontal cortex. Stimulation will be applied for 20 minutes at 2 mA.

DEVICESham Transcranial Direct Current Stimulation

Sham tDCS sessions will last 20 minutes

Sponsors

Federal University of Paraíba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Age of at least 18 years; * Chronic tinnitus for at least 6 months. * Age-adjusted normal (sensorineural) hearing

Exclusion criteria

* Pregnancy and/or lactation; * Concurrent treatment for tinnitus; * Prior exposure to transcranial direct current stimulation (tDCS); * History of epilepsy and/or seizures; * Electronic implants or metallic objects in body; * Skin conditions where electrodes will be applied; * Major neurological co-morbidities.

Design outcomes

Primary

MeasureTime frameDescription
Tinnitus Handicap InventoryTHI will be measured before intervention (baseline), after 5 daily sessions (day 5) and 1 month after the last intervention.Assesses change in tinnitus from baseline to follow-up periods post interventions

Secondary

MeasureTime frameDescription
Visual Analogue Scales (VAS) of perceived tinnitus loudness and distressVisual analogue scale of tinnitus wiil be recorded at baseline (before intervention), before and after daily sessions with tDCS (day 1 to 5) , and 1 month after the last intervention.Self assessment of tinnitus loudness and tinnitus distress.
AcuphenometryAcufhenometry wiil be recorded at baseline (before intervention), before and after daily sessions with tDCS (day 1 to 5) , and 1 month after the last intervention.Subjective assessment of the frequency, intensity and type of tinnitus.

Countries

Brazil

Contacts

Primary ContactDayse Souza
dayse.s.s@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026